INTERNATIONAL STEM CELL CORP COM (ISCO)

Overview Price 0.35 Price Change Today +$0.01 (+2.94%) P&P rating Zacks Rank 3 - HOLD Open Price $0.33 Previous Close $0.34 Daily Range $0.33 - $0.35 52-Week Range $0.31 - $1.15 Volume 31,890 International Stem Cell Corporation is a biotechnology company currently focused on developing therapeutic and research products. In the area of therapeutic product development, ISCO's objective is to create an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease and retinal disease through cell transplant therapy. In furtherance of this objective, ISCO has developed pluripotent human stem cells from unfertilized human eggs, and techniques to cause those stem cells to be differentiated into the specific cell types required for transplant. It has developed manufacturing protocols to produce the cells minimizing contamination with animal by-products, a characteristic likely to be important in meeting U.S. Food and Drug Administration requirements. ISCO also provides the specialized cells and growth media needed for therapeutic cell transplantation research to academic and commercial researchers in related fields. Other Resources for ISCO Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Analyst Interview - International Stem Cell July 27, 2011 Zacks Blog: Analyst Interview - International Stem Cell July 27, 2011 International Stem Cell Corporation is a biotechnology company currently focused on developing therapeutic and research products. In the area of therapeutic product development, ISCO's objective is to create an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease and retinal disease through cell transplant therapy. In furtherance of this objective, ISCO has developed pluripotent human stem cells from unfertilized human eggs, and techniques to cause those stem cells to be differentiated into the specific cell types required for transplant. It has developed manufacturing protocols to produce the cells minimizing contamination with animal by-products, a characteristic likely to be important in meeting U.S. Food and Drug Administration requirements. ISCO also provides the specialized cells and growth media needed for therapeutic cell transplantation research to academic and commercial researchers in related fields.   Brokerage Analyst Recommendations 1 Brokerage Firms Covering ISCO   Strong Buy 0 Buy 0 Hold 1 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 3   ISCO Ratings: BUY  SELL  HOLD ISCO Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 0 Buy 0 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	07/27/11	Analyst Interview - International Stem Cell - Analyst Blog	0
Zacks_Analysts	0.00	08/25/10	Stem Cell Confusion Creates Opportunity - Analyst Blog	0

Commentary

There are no open picks with this stock at the moment.

Picks

There are no open picks with this stock at the moment.